News

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...
“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...
A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.
SUPER sensitive cancer blood tests will be rolled out to NHS patients in a world first. People diagnosed with breast or lung ...
Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...
CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...
Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) ...
Affinity Technologies, Inc. , a biotechnology company advancing noninvasive diagnostics and targeted therapeutics for cancer, today announced the U.S. Patent and Trademark Office (USPTO) has issued a ...
Ongoing research is focusing on combining cryoablation with immunotherapy to trigger stronger immune responses and redefine ...
AstraZeneca AZN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) rendered ...
A 56-year-old man presented for 3 weeks of intermittent blurred vision and photophobia.His medical history included type 2 diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease ...